Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US.

ABSTRACT:

Importance

Active surveillance (AS) is endorsed by clinical guidelines as the preferred management strategy for low-risk prostate cancer, but its use in contemporary clinical practice remains incompletely defined.

Objective

To characterize trends over time and practice- and practitioner-level variation in the use of AS in a large, national disease registry.

Design, setting, and participants

This retrospective analysis of a prospective cohort study included men with low-risk prostate cancer, defined as prostate-specific antigen (PSA) less than 10 ng/mL, Gleason grade group 1, and clinical stage T1c or T2a, newly diagnosed between January 1, 2014, and June 1, 2021. Patients were identified in the American Urological Association (AUA) Quality (AQUA) Registry, a large qua

SUBMITTER: Cooperberg MR 

PROVIDER: S-EPMC9982696 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature